US Stock MarketDetailed Quotes

Outlook Therapeutics (OTLK)

Watchlist
  • 0.3092
  • +0.0388+14.35%
Close Apr 17 15:59 ET
  • 0.3200
  • +0.0108+3.49%
Post 20:01 ET
32.35MMarket Cap-0.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics (OTLK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
-1.21M
1.41M
-91.79K
1.51M
0
0
0
0
0
0
Operating revenue
---1.21M
--1.41M
---91.79K
--1.51M
--0
--0
--0
--0
--0
--0
Cost of revenue
29.63K
1.36M
916.52K
439.82K
0
0
0
0
Gross profit
-1.24M
57.21K
-1.01M
1.07M
0
0
0
0
Operating expense
-43.32%12.25M
-6.39%67.12M
-28.72%16.31M
-14.05%16.81M
-34.57%12.39M
109.31%21.61M
34.97%71.7M
83.62%22.88M
7.83%19.56M
176.98%18.94M
Selling and administrative expenses
-27.91%8.61M
33.39%39.94M
-0.26%10.33M
15.77%9.68M
47.02%7.98M
106.20%11.95M
12.25%29.94M
37.78%10.35M
18.76%8.36M
-13.70%5.43M
-General and administrative expense
-27.91%8.61M
33.39%39.94M
-0.26%10.33M
15.77%9.68M
47.02%7.98M
106.20%11.95M
12.25%29.94M
37.78%10.35M
18.76%8.36M
-13.70%5.43M
Research and development costs
-62.38%3.63M
-34.92%27.18M
-52.26%5.98M
-36.31%7.13M
-67.38%4.41M
113.28%9.66M
57.88%41.76M
153.29%12.52M
0.90%11.2M
2,378.94%13.51M
Operating profit
37.59%-13.48M
6.47%-67.06M
24.32%-17.31M
19.50%-15.75M
34.57%-12.39M
-109.31%-21.61M
-34.97%-71.7M
-83.62%-22.88M
-7.83%-19.56M
-176.98%-18.94M
Net non-operating interest income expense
0
91.41%-193.39K
-172.69%-174.42K
-112.20%-49.35K
99.40%-18.5K
-74.09%48.88K
-44.31%-2.25M
-21.54%239.95K
2.37%404.59K
-1,742.24%-3.08M
Non-operating interest income
--0
-90.10%89.74K
----
----
----
-74.09%48.88K
-6.72%906.15K
-21.59%239.95K
2.29%404.59K
----
Non-operating interest expense
----
-91.03%283.13K
-60.35%264.16K
--49.35K
----
----
24.72%3.16M
323,297.57%666.2K
--0
----
Total other finance cost
----
----
----
----
-99.40%18.5K
----
----
----
----
1,742.24%3.08M
Other net income (expense)
-124.59%-9.57M
332.53%3.28M
-90.68%2.64M
-106.85%-4.35M
63.21%-33.94M
3,830.20%38.94M
67.16%-1.41M
3,482.31%28.33M
2,270.32%63.57M
-6,834,132.07%-92.26M
Gain on sale of security
-106.93%-2.79M
11.33%43.02M
-90.70%2.68M
-103.36%-2M
99.91%-51.15K
3,948.92%40.27M
75,781.38%38.64M
209,078.42%28.85M
506,136.45%59.45M
-372,395.68%-58.13M
Earnings from equity interest
-16.04%-38.63K
-39.97%-141.01K
-165.95%-40.42K
46.29%-30.88K
-19.00%-36.41K
-1,406.71%-33.3K
-816.00%-100.74K
-82.01%-15.2K
-699.90%-57.5K
-80.34%-30.6K
Special income (charges)
----
----
----
----
----
----
--0
--0
--0
--0
Other non- operating income (expenses)
-417.16%-6.74M
0.88%-39.6M
99.87%-641
-155.72%-2.32M
0.71%-33.86M
-31.32%-1.3M
-963.56%-39.95M
39.74%-508K
243.32%4.17M
-1,136,485.60%-34.1M
Income before tax
-232.69%-23.06M
15.11%-63.98M
-360.88%-14.85M
-145.38%-20.15M
59.44%-46.35M
255.46%17.38M
-27.78%-75.36M
143.81%5.69M
314.80%44.41M
-1,618.20%-114.29M
Income tax
-55,522.46%-1.55M
-1.55M
0
0.00%2.8K
0.00%2.8K
0
0
0.00%2.8K
Net income
-232.69%-23.06M
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
Net income continuous Operations
-232.69%-23.06M
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
Minority interest income
Net income attributable to the parent company
-232.69%-23.06M
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
Preferred stock dividends
Other preferred stock dividends
0
66.96M
Net income attributable to common stockholders
-232.69%-23.06M
17.17%-62.42M
-333.56%-13.29M
10.62%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
-9.05%-22.55M
-1,617.52%-114.29M
Basic earnings per share
-152.78%-0.38
55.91%-1.79
-125.00%-0.19
-128.80%-0.55
81.27%-1.5
183.72%0.72
13.98%-4.06
176.77%0.76
218.63%1.91
-1,440.38%-8.01
Diluted earnings per share
-152.78%-0.38
55.91%-1.79
-125.00%-0.19
38.20%-0.55
81.27%-1.5
183.72%0.72
13.98%-4.06
176.77%0.76
44.72%-0.89
-1,440.38%-8.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue -1.21M1.41M-91.79K1.51M000000
Operating revenue ---1.21M--1.41M---91.79K--1.51M--0--0--0--0--0--0
Cost of revenue 29.63K1.36M916.52K439.82K0000
Gross profit -1.24M57.21K-1.01M1.07M0000
Operating expense -43.32%12.25M-6.39%67.12M-28.72%16.31M-14.05%16.81M-34.57%12.39M109.31%21.61M34.97%71.7M83.62%22.88M7.83%19.56M176.98%18.94M
Selling and administrative expenses -27.91%8.61M33.39%39.94M-0.26%10.33M15.77%9.68M47.02%7.98M106.20%11.95M12.25%29.94M37.78%10.35M18.76%8.36M-13.70%5.43M
-General and administrative expense -27.91%8.61M33.39%39.94M-0.26%10.33M15.77%9.68M47.02%7.98M106.20%11.95M12.25%29.94M37.78%10.35M18.76%8.36M-13.70%5.43M
Research and development costs -62.38%3.63M-34.92%27.18M-52.26%5.98M-36.31%7.13M-67.38%4.41M113.28%9.66M57.88%41.76M153.29%12.52M0.90%11.2M2,378.94%13.51M
Operating profit 37.59%-13.48M6.47%-67.06M24.32%-17.31M19.50%-15.75M34.57%-12.39M-109.31%-21.61M-34.97%-71.7M-83.62%-22.88M-7.83%-19.56M-176.98%-18.94M
Net non-operating interest income expense 091.41%-193.39K-172.69%-174.42K-112.20%-49.35K99.40%-18.5K-74.09%48.88K-44.31%-2.25M-21.54%239.95K2.37%404.59K-1,742.24%-3.08M
Non-operating interest income --0-90.10%89.74K-------------74.09%48.88K-6.72%906.15K-21.59%239.95K2.29%404.59K----
Non-operating interest expense -----91.03%283.13K-60.35%264.16K--49.35K--------24.72%3.16M323,297.57%666.2K--0----
Total other finance cost -----------------99.40%18.5K----------------1,742.24%3.08M
Other net income (expense) -124.59%-9.57M332.53%3.28M-90.68%2.64M-106.85%-4.35M63.21%-33.94M3,830.20%38.94M67.16%-1.41M3,482.31%28.33M2,270.32%63.57M-6,834,132.07%-92.26M
Gain on sale of security -106.93%-2.79M11.33%43.02M-90.70%2.68M-103.36%-2M99.91%-51.15K3,948.92%40.27M75,781.38%38.64M209,078.42%28.85M506,136.45%59.45M-372,395.68%-58.13M
Earnings from equity interest -16.04%-38.63K-39.97%-141.01K-165.95%-40.42K46.29%-30.88K-19.00%-36.41K-1,406.71%-33.3K-816.00%-100.74K-82.01%-15.2K-699.90%-57.5K-80.34%-30.6K
Special income (charges) --------------------------0--0--0--0
Other non- operating income (expenses) -417.16%-6.74M0.88%-39.6M99.87%-641-155.72%-2.32M0.71%-33.86M-31.32%-1.3M-963.56%-39.95M39.74%-508K243.32%4.17M-1,136,485.60%-34.1M
Income before tax -232.69%-23.06M15.11%-63.98M-360.88%-14.85M-145.38%-20.15M59.44%-46.35M255.46%17.38M-27.78%-75.36M143.81%5.69M314.80%44.41M-1,618.20%-114.29M
Income tax -55,522.46%-1.55M-1.55M00.00%2.8K0.00%2.8K000.00%2.8K
Net income -232.69%-23.06M17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M
Net income continuous Operations -232.69%-23.06M17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M
Minority interest income
Net income attributable to the parent company -232.69%-23.06M17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M
Preferred stock dividends
Other preferred stock dividends 066.96M
Net income attributable to common stockholders -232.69%-23.06M17.17%-62.42M-333.56%-13.29M10.62%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M-9.05%-22.55M-1,617.52%-114.29M
Basic earnings per share -152.78%-0.3855.91%-1.79-125.00%-0.19-128.80%-0.5581.27%-1.5183.72%0.7213.98%-4.06176.77%0.76218.63%1.91-1,440.38%-8.01
Diluted earnings per share -152.78%-0.3855.91%-1.79-125.00%-0.1938.20%-0.5581.27%-1.5183.72%0.7213.98%-4.06176.77%0.7644.72%-0.89-1,440.38%-8.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -